Edition:
United States

American Vanguard Corp (AVD)

AVD on New York Consolidated

20.05USD
23 Aug 2017
Change (% chg)

$0.20 (+1.01%)
Prev Close
$19.85
Open
$19.75
Day's High
$20.10
Day's Low
$19.75
Volume
16,304
Avg. Vol
95,987
52-wk High
$20.85
52-wk Low
$14.20

AVD

Chart for AVD

About

American Vanguard Corporation operates as a holding company. The Company conducts its business through its subsidiaries, AMVAC Chemical Corporation (AMVAC), GemChem, Inc. (GemChem), 2110 Davie Corporation (DAVIE), Quimica Amvac de Mexico S.A. de C.V. (AMVAC M), AMVAC Mexico Sociedad de Responsabilidad Limitada (AMVAC M Srl),... (more)

Overall

Beta: 1.25
Market Cap(Mil.): $591.21
Shares Outstanding(Mil.): 29.78
Dividend: 0.01
Yield (%): 0.30

Financials

  AVD Industry Sector
P/E (TTM): 40.44 22.56 49.65
EPS (TTM): 0.49 -- --
ROI: 4.39 2.99 9.11
ROE: 5.13 5.04 11.72

BRIEF-American Vanguard's unit acquires certain herbicide and fungicide products from Syngenta in Mexico

* Amvac Mexico Srl acquires certain herbicide and fungicide products from Syngenta in Mexico

9:13am EDT

BRIEF-American Vanguard's subsidiary AMVAC Chemical signs non-binding memorandum of understanding with Trimble

* American Vanguard Corp - Its wholly owned subsidiary AMVAC Chemical Corporation has signed a non-binding memorandum of understanding with Trimble Inc

Aug 21 2017

BRIEF-American Vanguard reports Q2 earnings per share $0.15

* American Vanguard reports second quarter & mid-year 2017 results

Jul 31 2017

BRIEF-American vanguard enters into agreement with Adama to acquire certain crop protection assets in U.S.

* American Vanguard enters into agreement with Adama to acquire certain crop protection assets in the U.S.

Apr 05 2017

BRIEF-American Vanguard announces new head of regulatory affairs

* American vanguard announces new head of regulatory affairs Source text for Eikon: Further company coverage:

Mar 21 2017

BRIEF-American Vanguard Q4 EPS $0.13

* American Vanguard reports fourth quarter & full year 2016 results

Mar 06 2017

Earnings vs. Estimates